$PODC
PodcastOne, Inc. Stock $podc

$podc Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924026430 Filed on August 13, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$12.15M	$13.16M	$10.64M
YoY Change	15.58%	23.71%	22.04%
Cost Of Revenue	$11.14M	$11.71M	$8.222M
YoY Change	23.02%	42.41%	24.94%
Gross Profit	$1.012M	$1.450M	$2.415M
YoY Change	-30.64%	-39.96%	13.11%
Gross Profit Margin	8.33%	11.02%	22.7%
Selling, General & Admin	$2.329M	$2.245M	$2.170M
YoY Change	-12.64%	3.46%	-14.09%
% of Gross Profit	230.14%	154.83%	89.86%
Research & Development	$13.00K	$18.00K	$27.00K
YoY Change	-53.57%	-33.33%	-58.46%
% of Gross Profit	1.28%	1.24%	1.12%
Depreciation & Amortization	$60.00K	$443.0K	$86.00K
YoY Change	-40.0%	415.12%	14.67%
% of Gross Profit	5.93%	30.55%	3.56%
Operating Expenses	$2.342M	$2.263M	$2.197M
YoY Change	-13.07%	3.0%	-15.21%
Operating Profit	-$1.658M	-$1.366M	$193.0K
YoY Change	16.27%	-807.77%	-140.12%
Interest Expense		$0.00	$1.593M
YoY Change		-100.0%
% of Operating Profit			825.39%
Other Income/Expense, Net	$0.00	$0.00	-$403.0K
YoY Change	-100.0%	-100.0%
Pretax Income	-$1.658M	-$1.366M	-$210.0K
YoY Change	-84.75%	550.48%	-56.34%
Income Tax	$11.00K	$0.00
% Of Pretax Income
Net Earnings	-$1.669M	-$1.366M	-$210.0K
YoY Change	-84.65%	550.48%	-56.34%
Net Earnings / Revenue	-13.73%	-10.38%	-1.97%
Basic Earnings Per Share	-$0.07	-$0.06	-$0.01
Diluted Earnings Per Share		-$0.06	-$0.01
COMMON SHARES
Basic Shares Outstanding	24.02M	23.79M	20.00M shares
Diluted Shares Outstanding			20.00M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$891.0K	$470.0K
YoY Change		89.57%
Cash & Equivalents	$1.355M	$891.0K	$468.0K
Short-Term Investments
Other Short-Term Assets		$1.183M	$1.130M
YoY Change		4.69%
Inventory
Prepaid Expenses
Receivables	$6.324M	$7.100M	$8.790M
Other Receivables		$0.00	$900.0K
Total Short-Term Assets	$8.340M	$9.174M	$10.39M
YoY Change	-25.21%	-11.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$311.0K	$316.0K	$229.0K
YoY Change	31.78%	37.99%
Goodwill	$12.04M	$12.04M	$12.04M
YoY Change	0.0%	0.0%
Intangibles	$2.146M	$2.474M	$707.0K
YoY Change	-23.93%	249.93%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$14.78M	$14.83M	$16.82M
YoY Change	-14.39%	-11.84%
TOTAL ASSETS
Total Short-Term Assets	$8.340M	$9.174M	$10.39M
Total Long-Term Assets	$14.78M	$14.83M	$16.82M
Total Assets	$23.12M	$24.01M	$27.21M
YoY Change	-18.64%	-11.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$1.174M	$1.960M
YoY Change		-40.1%
Accrued Expenses		$6.891M	$6.100M
YoY Change		12.97%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00	$5.630M
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.594M	$8.285M	$20.22M
YoY Change	-30.18%	-59.02%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$46.00K	$46.00K
YoY Change	-82.03%
Total Long-Term Liabilities	$46.00K	$46.00K	$0.00
YoY Change	-82.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.594M	$8.285M	$20.22M
Total Long-Term Liabilities	$46.00K	$46.00K	$0.00
Total Liabilities	$7.640M	$8.331M	$20.22M
YoY Change	-31.37%	-58.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.60M	-$31.00M	-$12.88M
YoY Change	25.38%	140.76%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.48M	$15.67M	$6.993M
YoY Change
Total Liabilities & Shareholders Equity	$23.12M	$24.01M	$27.21M
YoY Change	-18.64%	-11.78%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.669M	-$1.366M	-$210.0K
YoY Change	-84.65%	550.48%	-56.34%
Depreciation, Depletion And Amortization	$60.00K	$443.0K	$86.00K
YoY Change	-40.0%	415.12%	14.67%
Cash From Operating Activities		-$480.0K	-$46.00K
YoY Change		943.48%	-105.3%
INVESTING ACTIVITIES
Capital Expenditures		$74.00K	$48.00K
YoY Change		54.17%	-11.11%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$74.00K	-$48.00K
YoY Change		54.17%	-11.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$0.00	-$3.000M
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities		-$480.0K	-$46.00K
Cash From Investing Activities		-$74.00K	-$48.00K
Cash From Financing Activities		$0.00	-$3.000M
Net Change In Cash		-$554.0K	-$3.094M
YoY Change		-82.09%	-480.1%
FREE CASH FLOW
Cash From Operating Activities		-$480.0K	-$46.00K
Capital Expenditures		$74.00K	$48.00K
Free Cash Flow		-$554.0K	-$94.00K
YoY Change		489.36%	-111.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	dei	Amendment Flag AmendmentFlag	false
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23791767
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23791767
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23608049
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23608049
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	dei	Document Type DocumentType	10-Q
CY2024Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q2	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q2	dei	Entity File Number EntityFileNumber	001-41795
CY2024Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-2503373
CY2024Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	269 S. Beverly Dr. Suite #1450
CY2024Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Beverly Hills
CY2024Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90212
CY2024Q2	dei	City Area Code CityAreaCode	310
CY2024Q2	dei	Local Phone Number LocalPhoneNumber	858-0888
CY2024Q2	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value per share
CY2024Q2	dei	Trading Symbol TradingSymbol	PODC
CY2024Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q2	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q2	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24016767
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	891000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1445000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7100000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6023000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1183000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1105000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	9174000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	8573000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	316000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	309000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	12041000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	12041000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2474000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3145000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	0	usd
CY2024Q1	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	57000	usd
CY2024Q2	us-gaap	Assets Assets	24005000	usd
CY2024Q1	us-gaap	Assets Assets	24125000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8285000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7698000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	46000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	86000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	8331000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	7784000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	46651000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45952000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30977000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29611000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	15674000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	16341000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24005000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24125000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13159000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10637000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11709000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8222000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	847000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1250000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1398000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	920000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	377000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	176000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	14525000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	10444000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1366000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	193000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	-0	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1593000	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-0	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1190000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-403000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1366000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-210000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1366000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-210000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23712530
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20000000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	16341000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	220000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	174000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	305000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1366000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	15674000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	7119000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	84000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-210000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6993000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1366000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-210000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	443000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	86000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	394000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	84000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1475000	usd
CY2024Q2	podc	Change In Fair Value Of Bifurcated Embedded Derivatives ChangeInFairValueOfBifurcatedEmbeddedDerivatives	0	usd
CY2023Q2	podc	Change In Fair Value Of Bifurcated Embedded Derivatives ChangeInFairValueOfBifurcatedEmbeddedDerivatives	-1190000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	176000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-44000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	49000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1033000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1968000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	77000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	120000	usd
CY2024Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-39000	usd
CY2023Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	588000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1066000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1160000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-480000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-46000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-74000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48000	usd
CY2024Q2	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	-0	usd
CY2023Q2	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3000000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3000000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-554000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3094000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1445000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3562000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	891000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	468000	usd
CY2024Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024Q2	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024Q2	podc	Common Stock Accrued To Repay Intercompany Balance CommonStockAccruedToRepayIntercompanyBalance	174000	usd
CY2023Q2	podc	Common Stock Accrued To Repay Intercompany Balance CommonStockAccruedToRepayIntercompanyBalance	0	usd
CY2024Q2	podc	Accrued Expenses Written Off Associated With Intangible Asset Impairment AccruedExpensesWrittenOffAssociatedWithIntangibleAssetImpairment	118000	usd
CY2023Q2	podc	Accrued Expenses Written Off Associated With Intangible Asset Impairment AccruedExpensesWrittenOffAssociatedWithIntangibleAssetImpairment	0	usd
CY2024Q2	podc	Common Stock Accrued At Period End CommonStockAccruedAtPeriodEnd	305000	usd
CY2023Q2	podc	Common Stock Accrued At Period End CommonStockAccruedAtPeriodEnd	0	usd
CY2024Q2	us-gaap	Assets Net AssetsNet	16100000	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	900000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31000000	usd
CY2024Q2	podc	Working Capital WorkingCapital	900000	usd
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of the Company’s interim unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include revenue, allowance for doubtful accounts, the assigned value of acquired assets and assumed and contingent liabilities associated with business combinations and the related purchase price allocation, useful lives and impairment of property and equipment, intangible assets, goodwill and other assets, the fair value of the Company’s equity-based compensation awards and convertible debt and debt instruments, fair values of derivatives, and contingencies.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q2	us-gaap	Advertising Expense AdvertisingExpense	100000	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	100000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	891000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	468000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	7132000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	6099000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	32000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	76000	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	7100000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	6023000	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	200000	usd
CY2024Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Concentration of Credit Risk</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains cash balances at commercial banks. Cash balances commonly exceed the $250,000 amount insured by the Federal Deposit Insurance Corporation. The Company has <em style="font: inherit;">not</em> experienced any losses in such accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to any significant credit risk with respect to such cash and cash equivalents.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1097000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1024000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	781000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	715000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	316000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	309000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	100000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	100000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	12041000	usd
CY2024Q2	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2024Q2	us-gaap	Goodwill Goodwill	12041000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4797000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2323000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2474000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5092000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1947000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3145000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	200000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	892000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	915000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	338000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	109000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	101000	usd
CY2024Q2	podc	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	119000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2474000	usd
CY2024Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1174000	usd
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1529000	usd
CY2024Q2	podc	Accrued Revenue Share AccruedRevenueShare	4196000	usd
CY2024Q1	podc	Accrued Revenue Share AccruedRevenueShare	2945000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	2695000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	2909000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	8065000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	7383000	usd
CY2023Q4	podc	Warrants Embedded Redemption Liability Derivative And Fees WarrantsEmbeddedRedemptionLiabilityDerivativeAndFees	5800000	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1400000	usd
CY2024Q2	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	4300000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	600000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	500000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	500000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	7000000	usd
CY2022Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	9800000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	7000000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	5000000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	1	pure
CY2024Q2	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.05	pure
CY2024Q2	podc	Common Stock Shares Cancelled CommonStockSharesCancelled	127984230
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	110000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.87
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.87
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	130000
CY2024Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.64
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y5M8D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y5M23D
CY2024Q2	podc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingFairValue	300000	usd
CY2024Q2	podc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableFairValue	200000	usd
CY2023Q2	podc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingFairValue	700000	usd
CY2023Q2	podc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableFairValue	300000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	110000000

Files In Submission

Name	View Source	Status
0001437749-24-026430-index-headers.html	Edgar Link	pending
0001437749-24-026430-index.html	Edgar Link	pending
0001437749-24-026430.txt	Edgar Link	pending
0001437749-24-026430-xbrl.zip	Edgar Link	pending
ex_697369.htm	Edgar Link	pending
ex_697370.htm	Edgar Link	pending
ex_697371.htm	Edgar Link	pending
ex_697372.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
podc-20240630.xsd	Edgar Link	pending
podc20240630_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
podc-20240630_def.xml	Edgar Link	unprocessable
podc-20240630_lab.xml	Edgar Link	unprocessable
podc-20240630_pre.xml	Edgar Link	unprocessable
podc20240630_10q_htm.xml	Edgar Link	completed
podc-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODC
PodcastOne, Inc. Stock $podc

2024 Q3 Form 10-Q Financial Statement

#000143774924026430 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODC PodcastOne, Inc. Stock $podc

2024 Q3 Form 10-Q Financial Statement

#000143774924026430 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODC
PodcastOne, Inc. Stock $podc